Suppression of collagen-induced arthritis with a serine proteinase inhibitor (serpin) derived from myxoma virus
- 17 May 2014
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 153 (2) , 254-263
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A Randomized Controlled, Phase 2 Trial of the Viral Serpin Serp-1 in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary InterventionCirculation: Cardiovascular Interventions, 2010
- FcgammaRIII-Expressing Macrophages are Essential for Development of Collagen-Induced ArthritisScandinavian Journal of Immunology, 2006
- Myxoma viral serpin, Serp-1, a unique interceptor of coagulation and innate immune pathwaysThrombosis and Haemostasis, 2006
- Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cellsBlood, 2004
- Serp-1, a Viral Anti-inflammatory Serpin, Regulates Cellular Serine Proteinase and Serpin Responses to Vascular InjuryJournal of Biological Chemistry, 2003
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Suppression of Collagen-Induced Arthritis Using an Angiogenesis Inhibitor, AGM-1470, and a Microtubule Stabilizer, TaxolCellular Immunology, 1994
- Angiogenesis inhibition suppresses collagen arthritis.Journal of Experimental Medicine, 1992
- Suppression of Collagen‐Induced Arthritis by Combination Cyclosporin a and Methotrexate TherapyArthritis & Rheumatism, 1991
- Antigen-specific suppression of collagen arthritis by adoptive transfer of spleen cellsClinical Immunology and Immunopathology, 1984